Rocket Pharmaceuticals (RCKT) Long-Term Debt Repayments (2014 - 2015)
Rocket Pharmaceuticals' (RCKT) quarterly Long-Term Debt Repayments came in at $5.8 million in Q1 2015, up 711.19% quarter-over-quarter from $715000.0 in Q4 2014.
Rocket Pharmaceuticals (RCKT) Long-Term Debt Repayments (2014 - 2015) Analysis & Trends
Rocket Pharmaceuticals has disclosed Long-Term Debt Repayments across 2 years of filings, most recently posting $5.8 million for Q1 2015.
- Long-Term Debt Repayments for Q1 2015 came in at $5.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $5.8 million (changed N/A YoY), and the FY2015 annual result was $5.8 million, up 311.35% from the prior year.
- Long-Term Debt Repayments came in at $5.8 million for Q1 2015 at Rocket Pharmaceuticals, up from $715000.0 in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $5.8 million in Q1 2015 to a low of $715000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -21,671.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Rocket Pharmaceuticals | 296.03 Mn | 296.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 5.80 Mn |
| Mar 31, 2015 | 5.80 Mn |
| Dec 31, 2014 | 715,000.00 |
| Dec 31, 2014 | 715,000.00 |